Investor Alert: Biotech Innovator Announces Conditional Listing Approval from NYSE American

*|MC_PREVIEW_TEXT|* Dear Investor, Cybin (NEO:CYBN) ([OTCQB:CLXPF]( has already made headlines with their breakthrough therapy … They have filed over 13 patent applications. … and have raised over C$88M in financing rounds. Now – they celebrate one of their biggest milestones with a conditional listing approval from the NYSE American stock exchange. But just who exactly is Cybin? Cybin (NEO:CYBN) ([OTCQB:CLXPF]( is a leading biotechnology company focused on progressing psychedelic therapeutics by utilizing proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches and treatment regimens for psychiatric disorders. Cybin is giving new hope to millions of Americans suffering from chronic conditions, from anxiety and depression to PTSD … So much so that they’ve attracted significant interest from both the medical community and prominent investors. [Learn More About Cybin]( This is a chance for main street investors to get in early and capitalize – in a big way – on the company’s continued success. There’s a reason big-name investors like Peter Thiel and Shark Tank’s Kevin O’Leary are bullish on the future of psychotherapy. All the more reason to cash in now … That’s why we at Wasatch Investment Network (WIN) are sharing this with you — so that you can get in on the action before it’s too late. Wasatch Investment Network (WIN) is a group of professional investment analysts that together have the better part of a century’s worth of experience on Wall Street and in financial markets. Everyday, we bring unbiased coverage and insights on the biggest new opportunities for Main Street investors like yourself. Please [click here]( to subscribe to Wasatch Investment Network and learn more about this unique opportunity. Yours, Bob Byrne Partner, Wasatch Investment Network [Subscribe to Wasatch]( IMPORTANT NOTICE AND DISCLAIMER: All investments are subject to risk, which must be considered on an individual basis before making any investment decision. This paid advertisement includes a stock profile of Cybin, Inc. (NEO: CYBN) Wasatch Investment Network is an investment newsletter being advertised herein. This paid advertisement is intended solely for information and educational purposes and is not to be construed under any circumstances as an offer to buy or sell, or as a solicitation to buy or sell, any securities. In an effort to enhance public awareness of NEO: CYBN, provided advertising agencies with a total budget of approximately one $1,192,670 dollars to cover the costs associated with creating, printing and distribution of this advertisement March 4, 2021- August 15, 2021. Payor has represented to advertising agencies in writing that this advertising campaign is funded by NEO: CYBN, to be profiled in this advertisement after Wasatch Investment Network conducted an investigation of the company and its management. Wasatch Investment Network was paid thirty-five thousand dollars as a research fee. In addition, Wasatch Investment Network may receive subscription revenue in the future from new subscribers as a result of this advertisement. The advertising agencies will retain any excess sums after all expenses are paid. During the period of time this advertisement is being disseminated, neither Wasatch Investment Network, the advertising agencies, nor their respective officers, principals, or affiliates (as defined in the Securities Act of 1933, as amended, and Rule 501(b) promulgated thereunder) and will, receive or sell such securities of Cybin, Inc. for not less than 90 days following the conclusion of this advertising campaign. The Payor has represented in writing to Wasatch Investment Network and the advertising agencies that neither it nor its officers, principals, or affiliates (as defined in the Securities Act of 1933, as amended, and Rule 501(b) promulgated thereunder) owns or beneficially owns any securities of the NEO: CYBN or will purchase, receive, or sell any such securities for not less than 90 days following the conclusion of this advertising campaign. If successful, this advertisement will increase investor and market awareness, which may result in an increased number of shareholders owning and trading the securities of NEO: CYBN, increased trading volume, and possibly an increased share price of NEO: CYBN securities, which may be temporary. This advertisement, the advertising agencies and Wasatch Investment Network do not purport to provide a complete analysis of NEO: CYBN’s financial position. They are not, and do not purport to be, broker-dealers or registered investment advisors. This advertisement is not, and should not be construed to be, personalized investment advice directed to or appropriate for any particular investor. Any investment should be made only after consulting a registered broker-dealer or registered investment advisor or doing your own research if you do not utilize an investment professional to make decisions on what securities to buy and sell and only after reviewing the financial statements and other pertinent publicly-available information about NEO: CYBN and its industry. Further, readers are specifically urged to read and carefully consider the Risk Factors identified and discussed in NEO: CYBN SEC filings. Investing in microcap securities such as NEO: CYBN is speculative and carries a high degree of risk. Past performance does not guarantee future results. This advertisement is based exclusively on information generally available to the public and does not contain any material, non-public information. The information on which it is based is believed to be reliable. Nevertheless, the advertising agencies and Wasatch Investment Network cannot guarantee the accuracy or completeness of the information and are not responsible for any errors or omissions. This advertisement contains forward-looking statements, including statements regarding expected continual growth of NEO: CYBN and/or their industry. The advertising agencies and Wasatch Investment Network note that statements contained herein that look forward in time, which include everything other than historical information, involve risks and uncertainties that may affect NEO: CYBN actual results of operations. Factors that could cause actual results to differ include the size and growth of the market for NEO: CYBN products and/or services, the company’s ability to fund its capital requirements in the near term and long term, Federal and state regulatory issues pricing pressures, etc. Wasatch Investment Network is the publisher’s trademark. All trademarks used in this advertisement other than Wasatch Investment Network are the property of their respective trademark holders and no endorsement by such owners of the contents of this advertisement is made or implied. The advertising agencies and Wasatch Investment Network are not affiliated, connected, or associated with, and are not sponsored, approved, or originated by, the trademark holders unless otherwise stated. No claim is made to any rights in any third-party trademarks. Copyright © *|CURRENT_YEAR|* *|LIST:COMPANY|*, All rights reserved. *|IFNOT:ARCHIVE_PAGE|* *|LIST:DESCRIPTION|* Our mailing address is: Wasatch Investment Network 15511 Hwy 71 West, Ste 110-207, Bee Cave, TX 78738 Want to change how you receive these emails? You can [update your preferences](*|UPDATE_PROFILE|*) or [unsubscribe from this list](*|UNSUB|*). Notice: Please understand that by opting out from future emails from this advertiser, you are transferring or authorizing the transfer of your email address to the advertiser listed above. Zacks has no control over how your email address is used by the advertiser or other third parties. Accordingly, Zacks disclaims all responsibility and liability arising from the subsequent use of your email address that is made possible by your submission of your email address above. You are receiving this email from Zacks Investment Research because you chose to receive messages from Zacks’ partners on the Zacks web site(s). Please note that Zacks does not produce or endorse this product, and assumes no responsibility for the use thereof. Your privacy is important to us. Click here to see our Privacy Policy: [( If you do not wish to receive further email solicitations from Zacks on behalf of its partners, please click [here]( to unsubscribe. Zacks Investment Research 10 S. Riverside Plaza, Suite 1600 Chicago, IL 60606